Gene · 6590
Papers3,867
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,867
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease. | Cell Rep | 2023 | 37243592 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications. | Biology (Basel) | 2023 | 37237486 | PubTator, text mining | PubMed |
| Fpr2-/- Mice Developed Exacerbated Alcohol-Associated Liver Disease. | Biology (Basel) | 2023 | 37237453 | PubTator, text mining | PubMed |
| Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling. | Front Endocrinol (Lausanne) | 2023 | 37234801 | PubTator, text mining | PubMed |
| Immune stimulation recruits a subset of pro-regenerative macrophages to the retina that promotes axonal regrowth of injured neurons. | Acta Neuropathol Commun | 2023 | 37226256 | PubTator, text mining | PubMed |
| MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte-predominant Hodgkin lymphoma. | EJHaem | 2023 | 37206275 | PubTator, text mining | PubMed |
| A Case of Anaplastic Large Cell Lymphoma Misdiagnosed with Keloid. | Clin Cosmet Investig Dermatol | 2023 | 37200841 | PubTator, text mining | PubMed |
| Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial. | Respir Res | 2023 | 37198686 | PubTator, text mining | PubMed |
| Targeted Diode Laser Therapy for Oral and Perioral Capillary-Venous Malformation in Pediatric Patients: A Prospective Study. | Children (Basel) | 2023 | 37189860 | PubTator, text mining | PubMed |
| [Ceritinib as First-line Treatment for Advanced Lung Adenocarcinoma with COX7A2L-ALK Fusion: A Case Report and Literature Review]. | Zhongguo Fei Ai Za Zhi | 2023 | 37183647 | PubTator, text mining | PubMed |
| Neutrophil elastase: From mechanisms to therapeutic potential. | J Pharm Anal | 2023 | 37181292 | PubTator, text mining | PubMed |
| Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report. | Reumatol Clin (Engl Ed) | 2023 | 37179159 | PubTator, text mining | PubMed |
| TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma. | Acta Neuropathol Commun | 2023 | 37158962 | PubTator, text mining | PubMed |
| Internal Jugular Venous Thrombosis With Superior Vena Cava Syndrome: A Rare First Presentation of Gray Zone Lymphoma. | Cureus | 2023 | 37153303 | PubTator, text mining | PubMed |
| Modulation of pulmonary desmosomes by inhaler therapy in preterm-born children with bronchopulmonary dysplasia. | Sci Rep | 2023 | 37147394 | PubTator, text mining | PubMed |
Patients with schizophrenia and bipolar disorder display a similar global gene expression signature in whole blood that reflects elevated proportion of immature neutrophil cells with association to lipid changes. | Transl Psychiatry | 2023 | 37147304 | PubTator, text mining | PubMed |
| Translational fidelity screens in mammalian cells reveal eIF3 and eIF4G2 as regulators of start codon selectivity. | Nucleic Acids Res | 2023 | 37144468 | PubTator, text mining | PubMed |
| Redefining normal breast cell populations using long noncoding RNAs. | Nucleic Acids Res | 2023 | 37144467 | PubTator, text mining | PubMed |
| What is new in cancer-associated fibroblast biomarkers? | Cell Commun Signal | 2023 | 37143134 | PubTator, text mining | PubMed |
| The Secretome of Irradiated Peripheral Mononuclear Cells Attenuates Hypertrophic Skin Scarring. | Pharmaceutics | 2023 | 37111549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6590/papers?page=19